Dr. Brownstein, an esteemed epidemiologist, researcher at Boston Children’s Hospital and professor at Harvard Medical School, will assist on MINDCURE’s digital technology, data optimization and patient data security within iSTRYM, its psychedelic digital therapeutics platform VANCOUVER, BC, May 19, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “MINDCURE” or the…


Previous articleTryp Therapeutics Partners with Clinlogix for Clinical Trial Support
Next articleMydecine Provides Update on Spin-Out of U.S. Cannabis Assets